Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Investing Activities ₹-196 Cr₹-12,683 Cr₹-2,082 Cr₹-1,054 Cr₹-1,369 Cr

What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Investing Activities ratio of MANKIND PHARMA is ₹-196 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Investing Activities
Mar2026₹-196 Cr
Mar2025₹-12,683 Cr
Mar2024₹-2,082 Cr
Mar2023₹-1,054 Cr
Mar2022₹-1,369 Cr

How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2026 ₹-196 Cr
Negative
Mar2025 ₹-12,683 Cr
Negative
Mar2024 ₹-2,082 Cr
Negative
Mar2023 ₹-1,054 Cr
Negative
Mar2022 ₹-1,369 Cr -

Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,839.7 Cr -4.5% 2.7% -2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.5%

2.7%

-2.1%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses